Topal Tufan
Acta Chim Slov. 2021 Mar;68(1):88-101.
A detailed description of the two new pyridine ligands, (2E,3Z)-3-[2-(3-chloropyridin-2-yl)hydrazinylidene]-N-hydroxybutan-2-imine and 3-chloro-2-(2Z)-2-[1-(4 nitrophenyl)ethylidene]hydrazinyl, is reported. The synthesized compounds were characterized by spectroscopic studies, spectral features were performed by TD-DFT calculations. New-generation pyridine ligand of HL2 was also determinate by single-crystal X-ray diffraction and Hirshfeld surface analysis with two-dimensional fingerprint plots was used to analyze intermolecular interactions in crystals. Molecular-docking was performed to investigate the binding areas of chemical compounds, and the results showed the inhibitory activity of the studied HL1 and HL2 against E. coli. The results of the current study revealed the drug-likeness and bioactive properties of the ligands.
报道了两种新型吡啶配体,即(2E,3Z)-3-[2-(3-氯吡啶-2-基)肼叉]-N-羟基丁-2-亚胺和3-氯-2-(2Z)-2-[1-(4-硝基苯基)亚乙基]肼的详细描述。通过光谱研究对合成的化合物进行了表征,光谱特征通过TD-DFT计算进行。还通过单晶X射线衍射确定了新一代吡啶配体HL2,并使用二维指纹图谱的 Hirshfeld 表面分析来分析晶体中的分子间相互作用。进行了分子对接以研究化合物的结合区域,结果表明所研究的HL1和HL2对大肠杆菌具有抑制活性。当前研究结果揭示了这些配体的类药物性质和生物活性特性。